Oregon Prescription Drug Affordability Board Meeting, April 15, 2026
Oregon Prescription Drug Affordability Board · April 15, 2026
Board heard staff presentations on data and rubric methodology for the 2026 drug review cycle (including how APAC claims will be filtered for orphan-condition uses), received public comment from industry and rare-disease advocates, and received a presentation from Oregon Health Authority staff on ArrayRx/OPDP and Medicaid pharmacy purchasing.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.